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Abstract 
Introduction: The contribution of cranial and thoracic region electromyography (EMG) to diagnostic 
criteria for amyotrophic lateral sclerosis (ALS) has not been evaluated. 
Methods: Clinical and EMG data from each craniospinal region were retrospectively assessed in 470 
patients; 214 had ALS. Changes to diagnostic classification in Awaji-Shima and revised El Escorial 
criteria following withdrawal of cranial/thoracic EMG data were ascertained. 
Results: Sensitivity for lower motor neuron involvement in ALS was highest in cervical/lumbar 
regions; specificity was highest in cranial/thoracic regions. Cranial EMG contributed to 
definite/probable Awaji-Shima categorization in 1.4% of patients. Thoracic EMG made no 
contribution. For revised El Escorial criteria, cranial and thoracic data reclassified 1% and 5% of 
patients, respectively. 
Conclusion: Cranial EMG data make small contributions to both criteria, thoracic data contribute 
only to the revised El Escorial criteria. However, cranial and thoracic region abnormalities are specific 
in ALS. Consideration should be given to allowing greater diagnostic contribution from thoracic EMG. 
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Introduction 
 
Early diagnosis of amyotrophic lateral sclerosis (ALS) is important for patients, since time is a limited 
commodity. There is also a need for early recruitment into clinical trials of new agents while a viable 
pool of motor neurons still remains. To facilitate diagnosis, the El Escorial,1 revised El Escorial,2 and 
subsequent Awaji-Shima3 criteria all combine patterns of upper motor neuron (UMN) and lower 
motor neuron (LMN) abnormalities derived from the cranial, cervical, thoracic, and lumbar 
anatomical regions into a diagnostic algorithm. The El Escorial criteria maintain a clinical emphasis 
on diagnosis, with electromyography (EMG) data only able to contribute towards entry into a 
“laboratory-supported probable” category. The more recent Awaji-Shima criteria refer to the El 
Escorial criteria for detection of UMN signs but allocate equal value to EMG and the clinical 
examination for detection of LMN signs and also allow electrophysiological fasciculation potentials 
to serve as evidence of active denervation. This renders the laboratory-supported category of the El 
Escorial criteria obsolete, and has been shown to improve overall diagnostic sensitivity without 
compromising specificity.4-6  
A practical difficulty with these classification systems is that the ease of identification of signs of 
pathology, both through clinical and EMG examination, differs between anatomical regions. For 
example, in the thoracic region, the only available UMN sign is the absence of abdominal reflexes, 
which may be subject to a degree of modulation by higher centers  not seen in limb reflexes; with 
training the response can be either extinguished or enhanced7. In addition, EMG of cranial and 
thoracic innervated muscles (in practice, usually the tongue and thoracic paraspinal muscles) is often 
more challenging than limb muscles, particularly with respect to achieving muscle relaxation. As a 
consequence, studies of their use vary in the reported diagnostic utility.8-11 While previous studies 
have examined the distribution of EMG changes12 and the frequency of acute and chronic 
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neurogenic abnormalities in ALS,13 the contribution of the cranial and thoracic regions to diagnostic 
categorization has not been evaluated systematically.   
In this study, we aimed to determine whether such data (obtained in a routine clinical setting) were 
worthwhile, in terms of achieving an earlier diagnosis of clinically probable/definite ALS. We sought 
to address this issue through a large retrospective review of clinical and EMG data obtained at the 
time of referral to our tertiary referral ALS center. We hypothesized that cranial EMG would 
regularly contribute to diagnosis by current criteria, while thoracic EMG would not because of the 
lack of a reliable clinical UMN sign.  
 
Methods 
Study design and approval 
A retrospective review of clinical and EMG data obtained through routine clinical contact in a tertiary 
neuromuscular center in England was performed. The study was approved by the local institutional 
Review Board (project number 5250). Informed consent was not required by the review board.  
 
Subjects  
The EMG database at the Department of Clinical Neurophysiology, Royal Hallamshire Hospital, 
Sheffield, England, was interrogated for all patients referred between 2006-2011 for assessment of 
possible motor neuron disease/ALS. Neurophysiological investigations were carried out by 5 
experienced consultant clinical neurophysiologists as part of standard clinical care. Five hundred 
consecutive patients were identified, and all subjects with sufficient available clinical and EMG 
information were included.  
Initial classification and clinical outcomes 
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Clinical data were obtained from the first tertiary Neuromuscular Clinic letter; if such a letter was 
not available, then General Neurology Clinic findings were used.  Demographic and EMG data from 
the first examination performed at our institution were analyzed. Clinical course and outcome were 
determined from case notes. In the absence of post-mortem data, ALS patients were defined by 
clinical diagnosis and confirmed by death or consistent, deteriorating clinical course on follow-up of 
2-7 years duration. Patients were first allocated into the following diagnostic categories: ALS 
(defined as motor neuron disease with presence of both UMN and LMN signs), primary lateral 
sclerosis (UMN only; PLS), progressive muscular atrophy (LMN only; PMA), and non-motor neuron 
disease (non-MND).  
 
ALS patients: clinical examination findings 
The presence of UMN signs, LMN signs, combined signs, or no signs was recorded for each of 4 
craniospinal regions: cranial, cervical, thoracic, and lumbar. Spasticity, clonus, hyper-reflexia, 
preserved reflexes in a wasted limb, spreading of reflexes outside of the stimulated territory, frontal 
release signs (e.g. positive snouting reflex), pyramidal pattern weakness and/or extensor plantar 
responses were considered UMN signs. Flaccidity, fasciculations, wasting, and/or areflexia were 
considered LMN signs. For each region examined, findings were recorded as present, absent, or not 
documented. This allowed “clinical only” diagnostic categorization. 
 
ALS patients: EMG examination findings 
The presence of fibrillation potentials, positive sharp waves and/or fasciculation potentials (the 
latter only for Awaji-Shima criteria assessment)3 were considered evidence of active denervation and 
were recorded for each of the 4 craniospinal regions. Reinnervation changes were defined as any of 
the following: long duration motor unit potentials (MUPs), high amplitude MUPs, increased 
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polyphasia, reduced recruitment pattern, instability of MUPs, and/or jiggle. Judgements on the 
presence/absence of such findings were made in line with standard convention.14 Regions were 
classified as abnormal according to standard electrophysiological diagnostic criteria3,2,15.  The 
muscles examined, number of areas sampled in each muscle, time spent sampling at each insertion 
and quantification were at the discretion of the investigating consultant neurophysiologist. 
Paraspinal muscle data were taken only from thoracic region examinations. All data presented from 
the cranial region evaluation were from the tongue. 
 
ALS patients: sensitivity of clinical and EMG examinations by body region  
In this study, as in routine clinical practice, no “gold standard” to confirm the presence or absence of 
denervation in patients was available. The percentage of ALS patients with clinical LMN signs in each 
craniospinal region was reported as “sensitivity”, accepting the limitations of the term in this 
context; not all ALS patients necessarily have denervation in all anatomical segments at the time of 
diagnosis. This nomenclature is consistent with previous studies.15 
The percentage of ALS patients with EMG findings of both active and chronic denervation satisfying 
Awaji-Shima criteria was reported for each craniospinal region in the same manner. 
 
Specificity of EMG examination by body region 
The percentage of patients with EMG findings of both active and chronic denervation satisfying 
Awaji-Shima criteria in the non-MND group was calculated for each craniospinal region, subtracted 
from 100% and designated estimates of EMG “specificity”.   
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ALS patients: diagnosis by Awaji-Shima criteria 
The percentage of ALS patients fulfilling definite/probable diagnostic criteria solely on clinical 
grounds was reported.  
The percentage of ALS patients fulfilling definite/probable diagnostic criteria after pooling clinical 
and electrophysiological data was reported. 
 
ALS patients: diagnosis by revised El Escorial criteria 
The percentage of ALS patients fulfilling the different classes of the El Escorial diagnostic criteria was 
reported. EMG data in this analysis did not include fasciculation potentials as evidence for 
denervation2. 
 
ALS patients: concordance of clinical and Awaji-Shima EMG examinations  
Concordance of clinical and EMG findings in ALS patients was examined for each craniospinal region. 
For each patient and each region, concordance was defined as any of the following: i) presence of 
clinical LMN signs (no clinical UMN signs) and EMG changes satisfying Awaji-Shima criteria (“positive 
EMG”), i.e. both clinical and EMG evidence of LMN involvement; ii) clinical mixed UMN/LMN signs 
and positive EMG, i.e. both clinical and EMG evidence of LMN involvement; iii) normal clinical 
examination and Awaji-Shima EMG criteria not fulfilled (“negative EMG”), i.e. neither clinical nor 
EMG evidence of LMN involvement; iv) clinical UMN signs only and negative EMG, i.e. neither clinical 
nor EMG evidence of LMN involvement. Discordant findings were allocated to the following 3 
categories: i) clinical LMN signs but negative EMG; ii) normal clinical examination but positive EMG; 
or iii) clinical UMN signs only but positive EMG.  
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ALS patients: contribution of cranial and thoracic EMG to diagnosis 
The relative contribution of cranial and thoracic EMG was assessed by removing the relevant EMG 
data, each in turn, from the dataset, reassessing the percentage of patients with ALS classified as 
having definite/probable ALS by Awaji-Shima criteria, and reporting the difference. This analysis was 
then repeated applying the revised El Escorial criteria and reassessing laboratory-supported 
probable diagnostic categorization. 
 
ALS patients: counting cranial or thoracic EMG changes alone towards Awaji-Shima diagnostic 
criteria 
Following our initial results, 2 additional post-hoc analyses were performed. The percentage of 
patients with definite/probable ALS by Awaji-Shima criteria was re-estimated, this time allowing 
EMG changes of both active and chronic denervation to contribute alone without the necessity for 
associated clinical UMN signs. This was performed for the cranial and thoracic regions, each in turn.  
 
Results 
Subjects  
From the initial 500 patients, 470 had sufficient clinical and EMG data available for inclusion. Case 
notes were unobtainable for the remainder.  
 
Initial classification and clinical outcomes 
Of the 470 patients, 214 were diagnosed with ALS and followed a consistent clinical course. Of the 
214 patients, 76% had died of ALS by the time of case notes review. A further 10% were alive and 
following a deteriorating course consistent with ALS. The remaining 14% were following a 
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deteriorating course consistent with ALS at last assessment, and the diagnosis appeared secure, but 
did not undergo long-term follow-up care at our institution. The proportion of patients allocated to 
the ALS, PLS, PMA, and non-MND groups, together with relevant demographic data are reported in 
Figure 1a. Alternative diagnoses made in the non-MND group are reported in Figure 1b. 
 
ALS patients: sensitivity of clinical and EMG examinations by body region  
Sensitivity estimates for clinical and EMG examinations in each craniospinal region in the ALS group 
are reported in Table 1. 
 
Specificity of EMG examination by body region 
Specificity estimates for EMG examination in each craniospinal region, derived from the non-MND 
group, are reported in Table 2. 
 
ALS patients: diagnosis by Awaji-Shima criteria 
The percentage of patients in the ALS group fulfilling each diagnostic category with and without EMG 
data is illustrated in Figure 2. Overall, the percentage of patients diagnosable with definite/probable 
ALS at presentation increased from 54.2% to 70.1% by adding EMG to clinical data. 
 
ALS patients: concordance of clinical and Awaji-Shima EMG examinations  
Concordance of clinical and EMG examination findings in the ALS group is reported in Figure 3. 
Concordance was generally high in the cervical and lumbar regions. There were important 
differences in the sensitivity of clinical and EMG assessment in the cranial and thoracic regions.  
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ALS patients: contribution of cranial and thoracic EMG to diagnosis: Awaji-Shima 
Using Awaji-Shima criteria following withdrawal of cranial EMG data, 1.4% of patients were 
reallocated from probable/definite ALS to lower diagnostic categories. On withdrawal of thoracic 
EMG data, no patient changed diagnostic category. The detail of this analysis, summarizing shifts 
across each diagnostic category is shown in figure 4a. 
 
ALS patients: counting cranial or thoracic EMG changes alone for Awaji-Shima criteria 
In the thoracic region, eschewing clinical data and instead allowing only EMG data to count towards 
diagnostic criteria would result in re-categorization with greater confidence in 39% of patients who 
underwent thoracic EMG (67 of 170; figure 4b). In 28 of these 170 patients (16.5%), this maneuver 
led to reclassification into the probable/definite diagnostic categories. This compares to the 
contribution of thoracic EMG by current Awaji-Shima criteria of zero.  
 
In the cranial region, eschewing clinical data and instead allowing only EMG data to count towards 
diagnostic criteria resulted in re-categorization with greater confidence in 4% of patients who 
underwent cranial EMG (7 of 183). In 2 of these 183 patients (1.1%), this maneuver led to 
reclassification into the probable/definite categories. This percentage would be added to the 
contribution of cranial EMG by current Awaji-Shima criteria of 1.4%. 
 
Using the same EMG-only criteria for the non-MND cohort, 4/91 (4.4%) of patients examined with 
thoracic EMG had false positive changes fulfilling Awaji-Shima criteria. In 2 of these patients (2.2% of 
the tested cohort; figure 4c),  these changes resulted in erroneous re-categorization as 
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probable/definite ALS. However, in both patients, additional clinical and imaging findings facilitated 
the final diagnoses of multi-level radiculopathy and camptocormia of uncertain etiology.  
 
In the non-MND cohort, 3/137 (2.2%) patients examined with cranial EMG had false positive changes 
fulfilling Awaji-Shima criteria. In 1 patient (0.7% of the tested cohort), these changes resulted in 
erroneous re-categorization as probable/definite ALS (figure 4c). The final diagnosis in this patient, 
who had a history of rheumatoid arthritis, remained unclear, but did not appear consistent with ALS. 
 
ALS patients: contribution of cranial and thoracic EMG to diagnosis: revised El Escorial 
Diagnostic categorization of the ALS patients by revised El Escorial criteria is shown in figure 5. By 
these criteria, EMG data can only contribute to classification in the “laboratory-supported” category. 
Cranial and thoracic EMG data resulted in a shift from possible to laboratory-supported classification 
in 1% and 5% of patients, respectively.  
 
Discussion 
The key finding from this study is that neurophysiological examination of the thoracic region did not 
contribute to the Awaji-Shima classification of a single ALS patient in our large cohort. If the revised 
El Escorial criteria were used, a small number of patients moved from the possible into the 
“laboratory supported” classification as a result of thoracic EMG data. Cranial EMG data changed 
diagnostic classification for a small number of patients in both criteria. Thus, the most specific 
craniospinal segments in the EMG examination appear to make only a modest impact on the 
diagnostic stratification of patients.  
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The patients in our cohort seem to be representative of the general MND population. PLS and PMA 
patients represented 2% and 6% of our MND patient population, respectively, which is similar to 
previous reports 16,17. The percentage of patients with clinically probable/definite disease and the 
improvements in diagnostic sensitivity achieved by adding EMG to clinical data are comparable with 
previous studies 4,18. Most of the increase in diagnostic confidence by the Awaji-Shima classification 
was derived from EMG examination of the limbs, perhaps because limb-onset ALS is the most 
common form of disease presentation,19 or because clinical detection of UMN-only pathology 
together with EMG-only detection of LMN pathology occurs most frequently in the limbs (figure 3).  
Although cranial and thoracic EMG abnormalities were highly specific for ALS, these examinations 
rarely increased the certainty of diagnostic classification, which may in part be due to difficulties in 
objective clinical assessment of these regions.  
 
The difficulty of clinically assessing the thoracic region is well recognized by clinicians but not 
acknowledged by any of the diagnostic criteria. Identification of UMN pathology in the thoracic 
region relies on the absence of abdominal reflexes, which some clinicians consider unreliable and 
have been reported by some authorities to be absent in up to 15% of healthy individuals.20 There are 
some fundamental differences between the abdominal reflexes and the limb stretch reflexes; as an 
UMN sign it is notable by its absence, and previous work has demonstrated that  the response can 
be altered with conditioning stimuli , a phenomenon not seen in limb reflexes7, potentially 
complicating interpretation.  There are few studies on the sensitivity and specificity of this clinical 
sign in ALS. One such study reported absent abdominal reflexes in only 5% of prospectively recruited 
ALS patients21. To our knowledge specificity has not been studied. Additionally, fasciculations  may 
also be difficult to appreciate clinically in thoracic muscles and would appear to be identified less 
often by clinicians than in the other regions.  
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Such limitations, together with the specificity of thoracic EMG abnormalities, heighten the 
importance of EMG in this region. Previous data on the utility of thoracic EMG in diagnosis of ALS are 
conflicting. While limb muscles may demonstrate denervation changes more frequently than their 
thoracic counterparts,22 frequent detection of abnormalities in thoracic muscles has been reported 
in small cohorts.8 Thoracic EMG has been proposed as being useful in differentiating ALS from other 
motor syndromes.11 While there is documentation of spontaneous activity in the cervical23,24 and 
lumbar25 regions in healthy subjects, little has been reported for thoracic paraspinal muscles. A study 
of paraspinal motor units across all three spinal regions found spontaneous activity in under 1% of 
paraspinal levels examined, although the levels at which these observations were made was not 
explicitly stated26.  Our data, derived from ALS and non-MND cohorts of very similar demographics, 
suggest that thoracic EMG identifies subclinical LMN pathology in a large proportion of ALS patients 
and only rarely in non-MND cases. We conclude that thoracic EMG data have real clinical value as a 
distinguishing feature between ALS and other neuromuscular conditions. 
 
As abdominal reflexes appear to be considered non-specific and were not assessed by the clinicians 
in this study then, by Awaji-Shima conditions, there is only one scenario in which thoracic EMG could 
potentially increase diagnostic categorization, by identifying subclinical LMN signs below clinical 
UMN signs. In this instance thoracic EMG abnormalities could alter categorization from “does not 
meet criteria” to “possible ALS”. Such a scenario did not occur in any of our 470 patients; there was 
always sufficient clinical or electrophysiological evidence of denervation in other regions to result in 
categorization with higher certainty. Using the revised El Escorial standards, thoracic EMG made a 
small diagnostic contribution by revealing LMN pathology not identified on clinical grounds alone, 
which contributed to recategorization of a small number of patients from possible to laboratory-
supported. These observations may help explain the findings of a recent meta-analysis which found 
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that the Awaji-Shima criteria downgraded a minority of patients when compared directly against the 
revised El Escorial guidelines due to the requirement for UMN signs in 2 regions6. 
 
In our analysis, we explored a new approach to improve the utility of thoracic EMG by altering the 
Awaji-Shima thoracic region criteria to give the presence of EMG changes alone equal weighting to 
mixed UMN/LMN signs in the other 3 body regions. We recognize that this proposal is imperfect. In 
our analysis, sensitivity to categorize as definite/probable ALS increased by 16.5%, however, a small 
number of non-MND cases fell into higher diagnostic categories. In these cases, additional clinical 
and/or imaging features helped avoid misdiagnosis, emphasising that ALS remains a clinical 
diagnosis. Further work is required to determine the reproducibility of our results in other centers 
and also to determine whether thoracic UMN involvement can be demonstrated by other means in 
order to enable thoracic region EMG to make a significant diagnostic contribution by current criteria. 
By contrast, considering cranial EMG data alone added little diagnostic sensitivity. This is most likely 
due to the availability of reliable clinical UMN signs and also because of the discordance identified in 
clinical and electrophysiological examination in this region.  
 
In our dataset LMN abnormalities in the cranial region were more frequently identified clinically than 
with EMG. As our cranial region EMG data were obtained through examination of the tongue, this 
may relate to technical difficulties, such as the difficulty in achieving tongue relaxation. Reported 
detection rates for tongue EMG abnormalities in ALS vary,27,9,10 and such observations may depend 
upon the number/location of needle insertion sites. Conversely, clinical examination of the tongue 
may be prone to over-diagnosis of fasciculations, again due to incomplete muscle relaxation. A 
limitation of this study is that we are unable to determine which of these potential explanations was 
responsible for the discordance, as we lacked a “gold standard” for presence of denervation. From a 
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practical perspective, we conclude that clinical examination of the cranial region appears to offer 
sensitivity, and EMG adds value in specificity.  
 
The retrospective and observational nature of our study has several limitations. For example, while 
virtually all patients had a clinical assessment and cervical/lumbar EMG, cranial and thoracic EMG 
were performed in only 86% and 79% of ALS patients, respectively (Table 1). This could have biased 
the estimated frequencies of cranial and thoracic EMG abnormalities. In addition, the study did not 
involve a standardized clinical or EMG protocol. This meant that EMG data were taken from different 
muscles, with different numbers of sites sampled, and potentially different durations of sampling. 
We cannot exclude the possibility that such inter-operator differences could influence the reported 
frequency of spontaneous activity9. We also did not assess if EMG was undertaken in clinically 
normal/ abnormal muscles; however, a comparison of this nature is already available13.  Instead, our 
analysis was concerned with the value of findings in different craniospinal regions. While the lack of 
a protocol-driven assessment of the type associated with prospective research studies must be 
taken into account when interpreting the data, we consider our findings more representative of 
routine practice, and thus they are especially valid to the everyday clinical setting.  
 
In summary, our data indicate that cranial and thoracic EMG abnormalities are highly specific in ALS. 
However, they rarely contribute to increased diagnostic categorization using established criteria in a 
routine clinical setting. In particular, thoracic EMG appears to be restricted to improving diagnostic 
confidence outside of the Awaji-Shima criteria. In the future, new technologies may facilitate use of 
EMG data; for example, assessment of UMN involvement through threshold tracking transcranial 
magnetic stimulation28 could improve the diagnostic contribution of the thoracic region. In the 
meantime, in order to permit use of thoracic EMG abnormalities there are 2 options: either pay 
close attention to the abdominal reflexes (accepting that specificity is unknown) or, alternatively, 
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allow thoracic EMG data equivalence with combined UMN/LMN signs within diagnostic criteria until 
more effective means of identifying thoracic UMN pathology become available.  
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Figure legends 
Figure 1. Subject categorization by diagnosis. a) Demographic profile of each patient group. b) 
Breakdown of the alternative diagnoses in the non-MND group. 
 
Figure 2. Awaji-Shima diagnostic category at time of presentation. 
The percentage of ALS patients in each Awaji-Shima diagnostic category at presentation, taking into 
account only clinical data (left hand columns, black) and following pooling of both clinical and EMG 
data (right hand columns, grey). 
Figure 3. Concordance between clinical and Awaji-Shima electrophysiological examination findings in 
the ALS group. a) Table of all concordance data. Concordance was generally high in the cervical and 
lumbar regions. There were larger differences in the sensitivity of clinical and EMG assessment in the 
cranial and thoracic regions.  Discordant data characterized by clinical UMN signs only (i.e without 
clinical LMN signs) but positive EMG were responsible for the observed increase in diagnostic yield 
compared to clinical examination alone, by Awaji-Shima criteria (see Figure 2). b) Graph of 
differences in concordance between clinical and EMG assessment, in terms of sensitivity to detect 
LMN pathology. EMG appeared superior to clinical examination in the thoracic region, whereas 
clinical examination appeared superior to EMG examination in the cranial region. 
 
Figure 4. Effects of altering the contribution of cranial and thoracic EMG in the Awaji-Shima system. 
a) Percentage of ALS patients at the time of diagnosis allocated to different Awaji-Shima categories 
(black columns). Removing cranial EMG from the criteria reduced a small number of patients in the 
probable and definite groups into lower categories (white columns). Removing thoracic EMG data 
had no effect on categorization in any patient (grey columns). b). Removing clinical data and allowing 
EMG data alone to count toward categorization in the cranial region (black columns) or thoracic 
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region (grey columns) improved diagnostic confidence, most notably for the thoracic EMG group 
(left columns). A proportion of these patients now entered the definite/probable categories (right 
columns). c). Applying EMG-only diagnostic paradigms to non-MND patients resulted in a small 
number of false positive placements into probable/definite categories. The black column indicates 
the number of additional false positives incurred by allowing cranial EMG data alone and the grey 
column thoracic EMG data alone.  
 
Figure 5.  Contribution of thoracic and cranial EMG data to revised El Escorial classification. 
a) Diagnostic classification by revised El Escorial criteria in ALS patients. b) The percentage of 
patients moving from clinically possible to laboratory-supported categories as a result of thoracic 
(left column) and cranial region (right column) EMG data.  
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Abbreviations 
Electromyography – EMG 
Motor neuron disease - MND 
Amyotrophic lateral sclerosis – ALS 
Upper motor neuron – UMN 
Lower motor neuron – LMN 
Motor unit potentials – MUPs 
Primary lateral sclerosis – PLS 
Progressive muscular atrophy - PMA  
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Table 1. Sensitivity estimates for clinical and EMG examinations in the ALS group, by craniospinal 
region (n=214). 
Body region % patients with 
clinical LMN signs 
% patients with positive 
EMG fulfilling Awaji-Shima 
criteria  
Number of patients 
with both clinical 
and EMG data 
available 
Cranial 
 
49.8 24.6 183 
Cervical 
 
84.6 83.2 214 
Thoracic 
 
4.7 51.8 170 
Lumbar 
 
67.6 77.0 213 
 
 
Table 2. Specificity estimates for EMG examination in the non-MND group, by craniospinal region 
(n=238). 
Body region Specificity of EMG changes fulfilling Awaji-
Shima criteria (%) 
Number examined 
Cranial 
 
97.8 137 
Cervical 
 
89.2 238 
Thoracic 
 
95.6 91 
Lumbar 
 
81.0 226 
 
